GlassScriptPhysician profile
Judith A Hahn
NPI 1700974581
$4,504.09
in general payments reported to CMS, 2019-2025
14 companies · $936 in 2025
The $936 reported for 2025 was more than what 79% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $864 · 2022: $1,034 · 2023: $723 · 2024: $947 · 2025: $936.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,407 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,407.37 |
| Education | $199.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,253.57 | 2021-2025 | Caplyta |
| Abbvie INC. | $715.53 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $672.44 | 2022-2025 | Austedo, Uzedy, Austedo Xr |
| Neurocrine Biosciences, INC. | $412.87 | 2022-2025 | Ingrezza |
| Lundbeck LLC | $356.47 | 2021-2025 | Rexulti |
| Alkermes, INC. | $327.43 | 2021-2025 | Aristada, Lybalvi |
| Vanda Pharmaceuticals INC. | $259.47 | 2021-2025 | Fanapt, Hetlioz |
| Janssen Pharmaceuticals, INC | $172.71 | 2021-2024 | Spravato, Invega Sustenna, Invega Trinza |
| Otsuka America Pharmaceutical, INC. | $140.08 | 2021-2025 | Rexulti, Nuedexta, Abilify Asimtufii |
| Takeda Pharmaceuticals U.S.A., INC. | $118.97 | 2021-2022 | |
| Ucb, INC. | $22.65 | 2024 | Briviact |
| Idorsia Pharmaceuticals US INC | $19.46 | 2023 | Quviviq |
| Avanir Pharmaceuticals, INC. | $17.47 | 2022 | |
| Axsome Therapeutics, INC. | $14.97 | 2023 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Hahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.